AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 161 min read$ALHC

KAO JOHN E sold $356K of ALHC (indirect holdings)

KAO JOHN E (Chief Executive Officer) sold 27,400 indirectly-held shares of Alignment Healthcare, Inc. (ALHC) at $13.00 ($0.36M total) on 2026-09-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · KAO JOHN E
Published Sep 16, 2026, 9:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 10:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ALHC
Bearish
medium confidence
Mentioned
$ALHC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALHCBearishLow
01

Why it matters

Insider sales often lead to short‑term price weakness, especially for small caps.

02

Market read

The filing provides fresh insider‑sale data that may affect trader sentiment on ALHC.

03

What to watch

The CEO's remaining stake remains sizable, and the sale was pre‑planned.

Relevance 3/10Novelty 5/10Timing: filed Sep 16 2026

Background

Alignment Healthcare Inc. (ALHC) filed a Form 4 reporting the CEO's sale of shares under a 10b5‑1 plan.

Company-level read

Ticker impact

$ALHCBearishMedium confidence
Context

CEO sold 27,400 shares for $356,200 via a 10b5-1 plan, reducing his stake to 590,766 shares.

Expected impact

modest short‑term downside pressure

Evidence & confidence

A $356K sale by the CEO is material for a micro‑cap and often triggers sell‑offs.

Market effects

Sector

Minimal impact on the broader healthcare sector.

Regional

No significant regional effect.

Global

Limited to investors tracking insider activity.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event under a pre‑arranged plan, not a negative signal.

Key entities

  • Company
    Alignment Healthcare, Inc.

    US‑listed healthcare firm (NASDAQ: ALHC).

  • Executive
    John E. Kao

    Chief Executive Officer of Alignment Healthcare.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ALHC insider trading history →

Related articles

SEP 16
$ALHCMed

Alignment Healthcare extends retreat, falls an additional 16% (ALHC:NASDAQ)

Alignment Healthcare (ALHC) shares fell 16% on Wednesday, extending a 20% drop from the prior session. Management cited planned investments and medical-cost pressures at the Baird 2026 Global Healthcare Conference. The stock reached a 52-week low at $8.71, trading 45-54% below its 50/200-day averages. An analyst upgraded ALHC to Buy, noting operational progress but warning of potential volatility.

seekingalpha.com1 min
SEP 15
$ASTHMed

Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know

Several healthcare stocks fell after bipartisan lawmakers introduced the Protecting Approved Care Act, which aims to reform Medicare Advantage plans. The bill could increase medical loss ratios and administrative burdens for insurers. Astrana Health (ASTH) fell 2.7%, Clover Health (CLOV) 4.8%, Alignment Healthcare (ALHC) 12.6%, and Novavax (NVAX) 3.6%.

financialcontent.com2 min
SEP 15
$ALHCMed

ALHC Stock Tumbles After ‘Don’t Poke the Bear’ Silence On Star Ratings — CLOV Falls With It

Alignment Healthcare (ALHC) shares dropped 22% after executives declined to discuss next year's quality bonus and noted higher-than-expected hospital bills. CEO John Kao cited CMS sensitivity about commenting on Plan Preview 2. Clover Health (CLOV) also fell 9%. ALHC's CFO mentioned institutional cost headwinds but expects them to ease by 2027. Guidance remained unchanged.

stocktwits.com2 min
SEP 10
$PGNYHighAI 8/10

Spotting Winners: Progyny (NASDAQ:PGNY) And Health Insurance Providers Stocks In Q2

Progyny (PGNY) and other health insurers reported Q2 earnings, with revenues beating estimates by 2.8% but guidance below expectations. PGNY's revenue grew 5.3% YoY, missing EBITDA guidance. CVS Health (CVS) reported 7.3% YoY revenue growth, beating estimates. Molina Healthcare (MOH) saw a 4.8% YoY revenue decline. Alignment Healthcare (ALHC) grew 31.6% YoY, while Clover Health (CLOV) saw 55.6% YoY growth. Stocks have declined since earnings, except CLOV, which rose 4.3%.

tradingview.com3 min
AUG 18
$ALHCMed

Alignment Health seeks to have former exec's whistleblower suit tossed

Alignment Healthcare and executives filed to dismiss a whistleblower suit by former exec Hakan Kardes, who alleges earnings were artificially boosted for higher bonuses. The company claims Kardes resigned voluntarily and his claims are false. Kardes says he was forced out after reporting accounting irregularities, affecting EBITDA and executive bonuses. Shares dropped initially but rebounded.

fiercehealthcare.com5 min
AUG 12
$ALHCMed

Alignment Healthcare (ALHC) Stock Drops 16.7% After Whistleblower Accounting Allegations Trigger Securities Investigation

Kaplan Fox & Kilsheimer LLP said it is investigating potential securities violations at Alignment Healthcare, Inc. (NASDAQ: ALHC) after a whistleblower complaint alleging accounting irregularities that allegedly inflated previously reported and projected results. The complaint cites operating expenses allegedly misclassified as capital expenditures, affecting Adjusted EBITDA. On July 8, 2026, ALHC shares fell $4.02, or 16.7%, to close at $20.03.

kalkine.ca3 min